Dr. Shah is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
600 N Wolfe St
Baltimore, MD 21287Phone+1 410-955-5000
Education & Training
Johns Hopkins UniversityFellowship, Pediatric Hematology/Oncology, 2009 - 2012
Massachusetts General Hospital/Harvard Medical SchoolResidency, Internal Medicine/Pediatrics, 2004 - 2008
University of Illinois College of MedicineClass of 2004
Certifications & Licensure
MD State Medical License 2013 - 2025
DC State Medical License 2008 - 2018- American Board of Internal Medicine Internal Medicine
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- A Phase I Study of NK Cell Infusion Following Allogeneic Peripheral Blood Stem Cell Transplantation From Related or Matched Unrelated Donors in Pediatric Patients With Solid Tumors and Leukemias Start of enrollment: 2011 Jan 29
- Donor-Derived Anti-CD33 CAR T Cell Therapy (VCAR33) in Patients With Relapsed or Refractory AML After Allogeneic Hematopoietic Cell Transplant Start of enrollment: 2023 Dec 11
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 1 citationsNeed for standardization of cytokine profiling in CAR T cell therapy.D Nathan Biery, David P Turicek, Caroline Diorio, Brett A Schroeder, Nirali N Shah
Molecular Therapy. 2024-09-04 - 2125 citationsT cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trialDaniel W. Lee, James N. Kochenderfer, Maryalice Stetler-Stevenson, Yongzhi K Cui, Cindy Delbrook
Lancet. 2015-02-07 - 887 citationsCD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy.Terry J. Fry, Nirali N. Shah, Rimas J. Orentas, Maryalice Stetler-Stevenson, Constance M. Yuan
Nature Medicine. 2018-01-01
Press Mentions
CAR-T Therapy Is Effective in Younger Children with ALLSeptember 9th, 2022- FDA Panel Backs Gene Tx for Degenerative Brain Disorder in KidsJune 10th, 2022
- Investigators Aim to Increase CAR T‐Cell Research and Extend Its ReachOctober 23rd, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
